Mbx Biosciences Inc Share Price

NASDAQ: MBX

Small Cap

$10.12

+0.18

(+1.81%)

Live

as on September 18, 2025 at 10:41 pm IST

$₹

Mbx Biosciences Inc Stock Performance

as on September 18, 2025 at 10:41 pm IST

Day's Low
Day's High
$9.95
Day's Price Range
$10.46
$10.12
1.68%
Downside
3.36%
Upside
52 Week's Low
52 Week's High
$4.81
52-Week Price Range
$27.5
$10.12
52.50%
Downside
171.74%
Upside

Mbx Biosciences Inc share price movements today

Previous Close: $9.94
Open: $10.01
Volume: 254.2K
Day's Low - High: $9.95 - $10.46
52 Week Low - High: $4.81 - $27.5

Mbx Biosciences Inc Historical Returns

1 Month Return: -31.78 %
3 Month Return: -3.31 %
1 Year Return: -52.67 %
3 Year Return: 0 %
5 Year Return: 0 %

Mbx Biosciences Inc Stock Fundamentals & Key Indicators

Check Mbx Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$327.4M

EPS (TTM)

-2.7005

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

5398700.00%

Mbx Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mbx Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Mbx Biosciences Inc	NA	$327.4M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Mbx Biosciences Inc Stock including INR - Dollar returns

The Mbx Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y

Mbx Biosciences Inc investment value today

Current value as on today

₹53,144

Returns

₹46,856

(-46.86%)

Returns from Mbx Biosciences Inc Stock

₹51,810 (-51.81%)

Dollar Returns*

₹4,953 (+4.95%)

Mbx Biosciences Inc Stock's Interest Amongst Investors

Search interest for Mbx Biosciences Inc Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-55% versus previous 30 day period

Mbx Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	0	-	-
Gross Profit	0	-	0	0	0	0	0	0
Operating Income	-10	-9	-13	-16	-19	-18	-26	-21
EBITDA	-10	-7	-12	-15	-19	-20	-26	-21
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	-10	-8	-12	-15	-18	-15	-23	-19
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-10	-8	-12	-15	-18	-15	-23	-19
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-7020.72%	0.00%	0.00%

Mbx Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-
Gross Profit	0	0	0
Operating Income	-25	-35	-68
EBITDA	-25	-35	-67
Interest Expense	0	-	-
Depreciation	0	0	0
Income Before Tax	-26	-32	-61
Income Tax Expense	-	-	-
Net Income	-26	-32	-61
Net Profit Margin	0.00%	0.00%	0.00%

Mbx Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-10	-8	-12	-15	-18	-15	-23	-19
Operating Cash Flow	-7	-11	-10	-13	-14	-16	-22	-17
Investing Cash Flow	-18	-28	15	-7	-100	-67	3	25
Financing Cash Flow	68	0	0	-1	235	0	0	1
Change in Cash	42	-40	35	-22	120	-83	-19	9

Mbx Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024
Net Income	-32	-61
Operating Cash Flow	-31	-54
Investing Cash Flow	-30	-160
Financing Cash Flow	69	234
Change in Cash	6	18

Insights on Mbx Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 121.1%
NEGATIVE IMPACT
Price Dip
In the last 1 month, MBX stock has moved down by -31.8%

About Mbx Biosciences Inc

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. It has built its proprietary Precision Endocrine Peptide platform to develop precision peptide therapies that are designed to overcome key limitations of current peptide therapies. Its product candidates and programs include MBX 2109, MBX 1416 and Obesity portfolio. MBX 2109 is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. MBX 1416 is designed to be a long-acting glucagon-like peptide-1 (GLP-1), receptor antagonist, as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. MBX 4291 is designed to be a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide, receptor co-agonist prodrug.

Organisation	Mbx Biosciences Inc
Headquarters	11711 North Meridian Street, Carmel, IN, United States, 46032
CEO	Mr. Peter Kent Hawryluk MBA
E-voting on shares	Click here to vote

Key Management of Mbx Biosciences Inc

Name	Title
Mr. Peter Kent Hawryluk MBA	CEO, President & Director
Mr. Richard B. Bartram CPA	Chief Financial Officer
Dr. Salomon Azoulay M.D.	Chief Medical Officer
Dr. Chatan Charan Ph.D.	Senior VP of Pharmaceutical Development & Chemistry, Manufacturing and Controls
Mr. Mark Hope	Senior Vice President of Regulatory & Quality
Mr. Matt Gambino	Vice President of Marketing
Ms. Michelle Graham	Chief Human Resources Officer
Dr. Michael A. Dorato DABT, Ph.D.	Sr. Vice President of Discovery & Non-Clinical Development
Dr. Andreas Moraitis M.D.	Senior Vice President of Clinical Development

FAQs

What is Mbx Biosciences Inc share price today?

Mbx Biosciences Inc share price today is $10.12 as on September 18, 2025 at 10:41 pm IST. Mbx Biosciences Inc share today touched a day high of $10.46 and a low of $9.95.

What is the 52 week high and 52 week low for Mbx Biosciences Inc share?

Mbx Biosciences Inc share touched a 52 week high of $27.5 on November 6, 2024 and a 52 week low of $4.81 on April 7, 2025. Mbx Biosciences Inc stock price today i.e. September 18, 2025 at 10:41 pm IST is trending at $10.12,which is 63.20% down from its 52 week high and 110.53% up from its 52 week low.

What is Mbx Biosciences Inc's market capitalisation today?

Mbx Biosciences Inc market capitalisation is $0.00T as on September 18, 2025 at 10:41 pm IST.

How to invest in Mbx Biosciences Inc Stock (MBX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Mbx Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mbx Biosciences Inc Shares that will get you 0.1482 shares as per Mbx Biosciences Inc share price of $10.12 per share as on September 18, 2025 at 10:41 pm IST.

What is the minimum amount required to buy Mbx Biosciences Inc Stock (MBX) from India?

Indian investors can start investing in Mbx Biosciences Inc (MBX) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 10:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Mbx Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 10:42 pm IST). Based on Mbx Biosciences Inc share’s latest price of $10.12 as on September 18, 2025 at 10:41 pm IST, you will get 0.9881 shares of Mbx Biosciences Inc. Learn more about fractional shares .